CVR number 41778547
Industry 68.2030 Renting and operating of own or leased real estate

Terapeuterne i Mejlgade 46B ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.4% 0.4% 0.4% 0.4% 0.4%  
Bankruptcy risk  0.0% 0.0% 3.8% 4.9% 4.6%  
Credit score (0-100)  0 0 50 44 45  
Credit rating  N/A N/A BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 30.2 37.9 151  
EBITDA  0.0 0.0 30.2 37.9 151  
EBIT  0.0 0.0 6.6 -52.0 60.6  
Pre-tax profit (PTP)  0.0 0.0 -0.5 -59.5 60.1  
Net earnings  0.0 0.0 -0.4 -46.9 40.9  
Pre-tax profit without non-rec. items  0.0 0.0 -0.5 -59.5 60.1  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 165 289 199  
Shareholders equity total  0.0 0.0 39.6 -7.3 33.7  
Interest-bearing liabilities  0.0 0.0 47.3 79.3 14.2  
Balance sheet total (assets)  0.0 0.0 509 571 452  
Net Debt  0.0 0.0 -42.0 61.6 14.1  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 30.2 37.9 151  
Gross profit growth  0.0% 0.0% 0.0% 25.4% 297.2%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 509 571 452  
Balance sheet change%  0.0% 0.0% 0.0% 12.2% -20.9%  
Added value  0.0 0.0 30.2 -28.4 150.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 142 34 -180  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 -1.0 1.0  

Profitability 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 21.8% -137.3% 40.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 1.3% -9.5% 11.8%  
ROI %  0.0% 0.0% 7.2% -59.5% 90.7%  
ROE %  0.0% 0.0% -1.0% -15.4% 13.5%  

Solidity 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 0.0% 7.8% -1.3% 7.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -138.8% 162.5% 9.4%  
Gearing %  0.0% 0.0% 119.4% -1,087.9% 42.2%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 30.1% 12.3% 1.2%  

Liquidity 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.0 0.3 0.1 0.1  
Current Ratio  0.0 0.0 0.3 0.1 0.1  
Cash and cash equivalent  0.0 0.0 89.2 17.7 0.1  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -329.4 -502.3 -370.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0